Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
3 Biotech ; 13(9): 291, 2023 Sep.
Article in English | MEDLINE | ID: mdl-37547919

ABSTRACT

Plant-derived nanomaterials (PDNM) have gained significant attention recently due to their potential pharmacological applications against pathogenic microbes, antimicrobial resistance (AMR), and certain metabolic diseases. This review introduces the concept of PDNMs and their unique properties, including their small size, high surface area, and ability to penetrate biological barriers. Besides various methods for synthesizing PDNMs, such as green synthesis techniques that utilize plant extracts and natural compounds, the advantages of using plant-derived materials, such as their biocompatibility, biodegradability, and low toxicity, were elucidated. In addition, it examines the recent and emerging trends in nanomaterials derived from plant approaches to combat antimicrobial resistance and metabolic diseases. The sizes of nanomaterials and their surface areas are vital as they play essential roles in the interactions and relationships between these materials and the biological components or organization. We critically analyze the biomedical applications of nanoparticles which include antibacterial composites for implantable devices and nanosystems to combat antimicrobial resistance, enhance antibiotic delivery, and improve microbial diagnostic/detection systemsIn addition, plant extracts can potentially interfere with metabolic syndrome pathways; hence most nano-formulations can reduce chronic inflammation, insulin resistance, oxidative stress, lipid profile, and antimicrobial resistance. As a result, these innovative plant-based nanosystems may be a promising contender for various pharmacological applications.

2.
Toxicol Mech Methods ; 32(4): 243-258, 2022 May.
Article in English | MEDLINE | ID: mdl-34663170

ABSTRACT

Toxic metals such as aluminum accumulation in the brain have been associated with the pathophysiology of several neurodegenerative disorders. Bryophyllum pinnatum leaves contain a vast array of polyphenols, particularly flavonoids, that may play a role in the prevention of toxic and degenerative effects in the brain. This study assessed the neuro-restorative potential of leaves of B. pinnatum enriched flavonoid fraction (BPFRF) in aluminum-induced neurotoxicity in rats. Neurotoxicity was induced in male Wistar rats by oral administration of 150 mg/kg body weight of aluminum chloride (AlCl3) for 21 days. Rats were grouped into five (n = 6); Control (untreated), Rivastigmine group, AlCl3 group and BPFRF group (50 and 100 mg/kg b.wt.) for 21 days. Neuronal changes in the hippocampus and cortex were biochemically and histologically evaluated. Expression patterns of acetylcholinesterase (AChE) mRNA were assessed using semi-quantitative reverse-transcription-polymerase chain reaction protocols. Molecular interactions of BPFRF compounds were investigated in silico. The results revealed that oral administration of BPFRF ameliorated oxidative imbalance by augmenting antioxidant systems and decreasing lipid peroxidation caused by AlCl3. BPFRF administration also contributed to the down-regulation of AChE mRNA transcripts and improved histological features in the hippocampus and cortex. Molecular docking studies revealed strong molecular interactions between BPFRF compounds, catalase, superoxide dismutase and glutathione peroxidase Overall, these findings suggest the neuroprotective effect of Bryophyllum pinnatum against aluminum-induced neurotoxicity.


Subject(s)
Kalanchoe , Neuroprotective Agents , Acetylcholinesterase/metabolism , Aluminum/toxicity , Aluminum Chloride , Animals , Antioxidants/metabolism , Antioxidants/pharmacology , Antioxidants/therapeutic use , Flavonoids/pharmacology , Flavonoids/therapeutic use , Kalanchoe/metabolism , Male , Molecular Docking Simulation , Neuroprotective Agents/pharmacology , Neuroprotective Agents/therapeutic use , Oxidative Stress , Rats , Rats, Wistar
3.
Pharm Biol ; 59(1): 444-456, 2021 Dec.
Article in English | MEDLINE | ID: mdl-33930998

ABSTRACT

CONTEXT: Bryophyllum pinnatum (Lam.) Oken (Crassulaceae) is used traditionally to treat many ailments. OBJECTIVES: This study characterizes the constituents of B. pinnatum flavonoid-rich fraction (BPFRF) and investigates their antioxidant and anticholinesterase activity using in vitro and in silico approaches. MATERIALS AND METHODS: Methanol extract of B. pinnatum leaves was partitioned to yield the ethyl acetate fraction. BPFRF was isolated from the ethyl acetate fraction and purified. The constituent flavonoids were structurally characterized using UPLC-PDA-MS2. Antioxidant activity (DPPH), Fe2+-induced lipid peroxidation (LP) and anticholinesterase activity (Ellman's method) of the BPFRF and standards (ascorbic acid and rivastigmine) across a concentration range of 3.125-100 µg/mL were evaluated in vitro for 4 months. Molecular docking was performed to give insight into the binding potentials of BPFRF constituents against acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). RESULTS: UPLC-PDA-MS2 analysis of BPFRF identified carlinoside, quercetin (most dominant), luteolin, isorhamnetin, luteolin-7-glucoside. Carlinoside was first reported in this plant. BPFRF significantly inhibited DPPH radical (IC50 = 7.382 ± 0.79 µg/mL) and LP (IC50 = 7.182 ± 0.60 µg/mL) better than quercetin and ascorbic acid. Also, BPFRF exhibited potent inhibition against AChE and BuChE with IC50 values of 22.283 ± 0.27 µg/mL and 33.437 ± 1.46 µg/mL, respectively compared to quercetin and rivastigmine. Docking studies revealed that luteolin-7-glucoside, carlinoside and quercetin interact effectively with crucial amino acid residues of AChE and BuChE through hydrogen bonds. DISCUSSION AND CONCLUSIONS: BPFRF possesses an excellent natural source of cholinesterase inhibitor and antioxidant. The material could be further explored for the potential treatment of oxidative damage and cholinergic dysfunction in Alzheimer's disease.


Subject(s)
Antioxidants/analysis , Cholinesterase Inhibitors/analysis , Flavonoids/analysis , Kalanchoe , Plant Extracts/analysis , Tandem Mass Spectrometry/methods , Acetylcholinesterase/analysis , Antioxidants/chemistry , Butyrylcholinesterase/analysis , Cholinesterase Inhibitors/chemistry , Chromatography, High Pressure Liquid/methods , Computer Simulation , Crystallography, X-Ray/methods , DNA Fingerprinting/methods , Dose-Response Relationship, Drug , Flavonoids/chemistry , Humans , Plant Extracts/chemistry , Protein Structure, Secondary , Spectrometry, Mass, Electrospray Ionization/methods
4.
Int J Mol Sci ; 22(6)2021 Mar 11.
Article in English | MEDLINE | ID: mdl-33799652

ABSTRACT

The potential enhancement of metformin hydrochloride (MH) loaded in lipid vesicles targeting therapeutic efficacy on alloxan-induced diabetic rats was investigated. This involved lipid vesicles formulated with homogenously distributed nano-sized particles by a novel integrated process of multiple emulsification by membrane and solvent evaporation. The average diameter of the water-in-oil (W1/O), W1/O/W2 emulsion droplets, and lipid vesicles was 192 nm, 52 µm, and 173 nm, respectively. The entrapment yield of metformin hydrochloride (MH) in the prepared lipid vesicles was 40.12%. The metformin hydrochloride-loaded lipid vesicles (MH-LLVs) sustained the release of the entrapped drug over a 12-h period and reduced the plasma glucose level of diabetic rats by 77.4% compared with free MH solution (2-h period and 58.2%, respectively) after one week post-diabetic treatment through oral administration of MH-LLV and the free drug. The remarkable improvement in the biochemical parameters recorded in the MH-LLV-treated animals compared with those that received free MH solutions depicted an enhanced kidney function, liver function, as well as oxidative stress status. Pancreatic histology depicted a pancreas with intralobular ducts (ID) and exocrine secretory acini that characterize an intact pancreas, which suggests the ability of the MH-LLVs to restore pancreatic cells to normal, on a continued treatment. Overall, MH-LLV appears an encouraging extended-release formulation with enhanced bioavailability, sustained release, and improved antihyperglycemic potentials.


Subject(s)
Diabetes Mellitus, Experimental/drug therapy , Drug Delivery Systems/methods , Lipids/chemistry , Metformin/pharmacology , Animals , Biological Availability , Blood Glucose/metabolism , Delayed-Action Preparations/administration & dosage , Delayed-Action Preparations/pharmacokinetics , Delayed-Action Preparations/pharmacology , Diabetes Mellitus, Experimental/blood , Diabetes Mellitus, Experimental/metabolism , Drug Liberation , Emulsions/chemistry , Hypoglycemic Agents/administration & dosage , Hypoglycemic Agents/pharmacokinetics , Hypoglycemic Agents/pharmacology , Male , Metformin/administration & dosage , Metformin/pharmacokinetics , Particle Size , Rats, Wistar , Treatment Outcome
5.
J Tradit Complement Med ; 9(4): 278-284, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31453123

ABSTRACT

This study was aimed at investigating the antioxidant properties and membrane stabilization effects of Mucuna pruriens leaves on sickle erythrocyte as a possible means of sickle cell disease management. Pulverized plant material was extracted with methanol, filtered and concentrated at reduced pressure with a rotary evaporator. Phytochemical analysis and antioxidant studies of the extract were carried out using standard methods. Blood samples of volunteer sickle cell patients and healthy individuals used in the study were collected from the University of Nigeria Medical Centre and University campus community, Nsukka respectively. The genotypes of the individuals were confirmed by cellulose acetate paper electrophoresis. Water induced haemolysis of human red blood cell was used to assess membrane stabilization of the erythrocytes. Phytochemical result of the extract showed the presence of alkaloids, flavonoids, tannins, proteins, terpenoids, saponins, cardiac glycosides and anthraquinones. Antioxidant vitamins C and E were present in concentrations of 495.36 mg/100 g and 101.03 mg/100 g respectively. The percentage (%) scavenging activity of the 1,1-diphenyl-2-picrylhydrazyl radical (DPPH) and hydroxyl radical by the extract was significant. The extract exhibited membrane stabilization on both normal and sickle erythrocytes. The percentage (%) inhibition of haemolysis by the extract in both normal and sickle erythrocytes at different concentrations of 100, 200, 400, 600 and 800 µg/ml were significant and concentration dependent. We conclude that M. pruriens leaves have antioxidant properties and erythrocyte membrane stabilizing potentials and could be recommended for use in the management of patients with sickle cell anaemia.

SELECTION OF CITATIONS
SEARCH DETAIL
...